A comprehensive review of 3D cancer models for drug screening and translational research
Cancer Innovation · 2024-02 · 3 (1)
DOI: 10.1002/cai2.102 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Innovation, online erschienen am 22.12.2023. Verfasst von Karthikey Sharma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering Indian Institute of Technology (IIT) Hyderabad India. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The 3D cancer models fill the discovery gap of 2D cancer models and play an important role in cancer research. In addition to cancer cells, a range of other factors include the stroma, density and composition of extracellular matrix, cancer‐associated immune cells (e.g., cancer‐associated fibroblasts cancer cell‐stroma interactions and subsequent interactions, and a number of other factors (e.g., tumor vasculature and tumor‐like microenvironment in vivo) has been widely ignored in the 2D concept of culture. Despite this knowledge, the continued use of monolayer cell culture methods has led to the failure of a series of clinical trials. This review discusses the immense importance of tumor microenvironment (TME) recapitulation in cancer research, prioritizing the individual roles of TME elements in cancer histopathology. The TME provided by the 3D model fulfills the requirements of in vivo spatiotemporal arrangement, components, and is helpful in analyzing various different aspects of drug sensitivity in preclinical and clinical trials, some of which are discussed here. Furthermore, it discusses models for the co‐assembly of different TME elements in vitro and focuses on their synergistic function and responsiveness as tumors. Furthermore, this review broadly describes of a handful of recently developed 3D models whose main focus is limited to drug development and their screening and/or the impact of this approach in preclinical and translational research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering Indian Institute of Technology (IIT) Hyderabad India.
ORCID-Profile: Sreenath Dey, Rounik Karmakar, Aravind Kumar Rengan
Zitieren
APA
Sharma, K., Dey, S., Karmakar, R., & Rengan, A. K. (2024). A comprehensive review of 3D cancer models for drug screening and translational research. Cancer Innovation, 3(1). https://doi.org/10.1002/cai2.102
Vancouver
Sharma K, Dey S, Karmakar R, Rengan AK. A comprehensive review of 3D cancer models for drug screening and translational research. Cancer Innovation. 2024;3(1). doi:10.1002/cai2.102
BibTeX
@article{Sharma2024,
author = {Sharma, Karthikey and Dey, Sreenath and Karmakar, Rounik and Rengan, Aravind Kumar},
title = {A comprehensive review of 3D cancer models for drug screening and translational research},
journal = {Cancer Innovation},
year = {2024},
volume = {3},
number = {1},
doi = {10.1002/cai2.102}
}
EUVIMED